{"id":"https://genegraph.clinicalgenome.org/r/9c435fa7-ba68-4c48-93d6-e3b369bc4a3fv1.1","type":"EvidenceStrengthAssertion","dc:description":"*COL1A1* was first reported in relation to autosomal dominant combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1 (EDS/OI) in 2005 (Cabral et al., PMID: 15728585). Combined osteogenesis imperfecta and Ehlers-Danlos syndrome-1 (OIEDS1) is an autosomal dominant generalized connective tissue disorder characterized by features of both osteogenesis imperfecta (bone fragility, long bone fractures, blue sclerae) and Ehlers-Danlos syndrome (joint hyperextensibility, soft and hyperextensible skin, abnormal wound healing, easy bruising, vascular fragility). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in phenotypic variability. Therefore, the following disease entities have been split into eight disease entities, osteogenesis imperfecta, type I (OMIM:166200), osteogenesis imperfecta, type II (OMIM:166210), osteogenesis imperfecta, type III (OMIM:259420), osteogenesis imperfecta, type IV (OMIM:166220), Ehlers-Danlos Syndrome, arthrochalasia type, 1 (OMIM:130060), combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1 (OMIM:619115), Ehlers-Danlos Syndrome, classic type, 1 (not associated with *COL1A1* in OMIM), and Caffey disease (OMIM:114000). The split curations have been curated separately. Ten variants (missense) that have been reported in eleven probands in four publications (PMIDs: 15728585, 17078022, 17206620, 23692737) are included in this curation. The mechanism of pathogenicity is known to be due to interference with N-propeptide removal (PMID: 23692737). This gene-disease association is also supported by evidence supporting abnormal biochemical function consistent with disease, expression studies throughout the skeletal system, tendons, ligaments, and sclerae, and a mouse model recapitulating the human phenotype (animal models, expression studies, biochemical function studies) (PMIDs: 6519194, 16407265, 19669491, 24443344, 28206959). In summary, there is definitive evidence supporting the relationship between *COL1A1* and autosomal dominant combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Skeletal Disorders GCEP on the meeting date September 7, 2022 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/9c435fa7-ba68-4c48-93d6-e3b369bc4a3f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ac0eb1d7-5309-48a0-acd8-53de284f4e4b","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ac0eb1d7-5309-48a0-acd8-53de284f4e4b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2023-09-28T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/ac0eb1d7-5309-48a0-acd8-53de284f4e4b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2023-09-28T20:08:33.132Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac0eb1d7-5309-48a0-acd8-53de284f4e4b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac0eb1d7-5309-48a0-acd8-53de284f4e4b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86400d2a-0848-4282-931a-9fa0f8f97180","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44ea9af0-4884-4b8f-a679-7809da1d37b3","type":"Finding","dc:description":"COL1A1 is the predominant collagen comprising tendons and ligaments.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28206959","rdfs:label":"Expression in tendons and ligaments","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0d6173ab-997a-473e-abda-f48ec4af079d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71ac9102-a5f9-4e38-ab5b-dd5c7c9e8060","type":"Finding","dc:description":"COL1A1 is expressed throughout the skeletal system.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19669491","rdfs:label":"Expression in skeletal system.","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e2ecdc31-9e21-40d6-a794-b568ab438cbe","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2ce6a51-4c41-49b5-9794-6b617957fd78","type":"Finding","dc:description":"COL1A1 is the predominant collagen comprising human scleral tissue.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/6519194","rdfs:label":"Expression in scleral tissue","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/78fe7ec0-12e7-484c-b8aa-b42cbb076af6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/91c92309-381c-4526-ab51-b2324551ad62","type":"Finding","dc:description":"Many patients have joint hyperflexibility.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16407265","rdfs:label":"Incomplete or delayed N-propeptide cleavage","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ac0eb1d7-5309-48a0-acd8-53de284f4e4b_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5be7f32b-4eb8-43a5-9452-554c6238ba91","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/60c6fc15-b3a6-497b-8d2c-a3720f453b63","type":"Finding","dc:description":"This mouse model mirrors skin and bone fragility.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24443344","rdfs:label":"COL1A1 deficient mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/ac0eb1d7-5309-48a0-acd8-53de284f4e4b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/433de870-a9be-43eb-8c7b-ddd48915024c","type":"EvidenceLine","dc:description":"This score is upgraded by 0.5 points to reflect the Gly-X-Y substitution.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/433de870-a9be-43eb-8c7b-ddd48915024c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15728585","allele":{"id":"https://genegraph.clinicalgenome.org/r/3148f499-4084-4511-97bb-21300cca51b8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.761G>A (p.Gly254Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA257911"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/433de870-a9be-43eb-8c7b-ddd48915024c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Underwent 70–88% cleavage, suggesting that helices with one or two normal pro-α1(I) chains were processed, whereas the 25% of helices containing two mutant chains could not be cleaved.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/408153b9-d116-4c6d-a769-ba31e5761480","type":"EvidenceLine","dc:description":"This score is upgraded by 0.5 points to reflect the Gly-X-Y substitution.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/408153b9-d116-4c6d-a769-ba31e5761480_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15728585","allele":{"id":"https://genegraph.clinicalgenome.org/r/5f0700a8-c89f-4625-9b91-7b15434c9a6c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.634G>A (p.Gly212Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA291548077"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/408153b9-d116-4c6d-a769-ba31e5761480_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Underwent 70–88% cleavage, suggesting that helices with one or two normal pro-α1(I) chains were processed, whereas the 25% of helices containing two mutant chains could not be cleaved.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5e034fee-445b-4c49-b1f6-2483c6d9ccb8","type":"EvidenceLine","dc:description":"This score is upgraded by 0.5 points to reflect the Gly-X-Y substitution.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5e034fee-445b-4c49-b1f6-2483c6d9ccb8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15728585","allele":{"id":"https://genegraph.clinicalgenome.org/r/a287e986-795c-46f1-8258-031276f79f15","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.797G>A (p.Gly266Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA291547556"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/5e034fee-445b-4c49-b1f6-2483c6d9ccb8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Completely cleaved, but at a reduced rate compared with normal procollagen.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3e4afadf-385c-4665-834a-c1a77db1a144","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e4afadf-385c-4665-834a-c1a77db1a144_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15728585","allele":{"id":"https://genegraph.clinicalgenome.org/r/573b42be-b2ae-4918-bca1-9b47f51e5da1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000017.11:g.50198157T>A (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA291548211"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/3e4afadf-385c-4665-834a-c1a77db1a144_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"~25% of pro-α1(I) chains were processed in vitro from c.588+4A>T.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/81120ac9-ef26-43e6-ae4b-4cf6097ba9d5","type":"EvidenceLine","dc:description":"This score is upgraded by 0.5 points to reflect the Gly-X-Y substitution.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81120ac9-ef26-43e6-ae4b-4cf6097ba9d5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15728585","allele":{"id":"https://genegraph.clinicalgenome.org/r/83217f19-3d88-4fe5-8e3b-c10df3db463a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.572G>A (p.Gly191Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA127151"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/81120ac9-ef26-43e6-ae4b-4cf6097ba9d5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"~25% of pro-α1(I) chains were processed in vitro","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9cd18181-19f9-44bd-9bd6-088028684482","type":"EvidenceLine","dc:description":"This score is upgraded by 0.5 points to reflect the Gly-X-Y substitution.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9cd18181-19f9-44bd-9bd6-088028684482_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23692737","allele":{"id":"https://genegraph.clinicalgenome.org/r/eccf9dba-abde-49d2-bb96-f613ec6200f4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.607G>T (p.Gly203Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400225250"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/9cd18181-19f9-44bd-9bd6-088028684482_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Pattern of pepsin-digested type I collagen retained in the cells, and secreted in the medium was abnormal. An extra band of higher molecular weight, suggestive for presence of mutant α1(I)-collagen dimers, was observed in both cell layer and medium fraction.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ea837ef0-c269-4fb7-ace5-30ba8a31db04","type":"EvidenceLine","dc:description":"This score is upgraded by 0.5 points to reflect the Gly-X-Y substitution.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea837ef0-c269-4fb7-ace5-30ba8a31db04_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23692737","allele":{"id":"https://genegraph.clinicalgenome.org/r/dfd9fc0a-1c85-4341-acf5-1831319d7a0f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.563G>A (p.Gly188Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400225653"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/ea837ef0-c269-4fb7-ace5-30ba8a31db04_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Pattern of pepsin-digested type I collagen retained in the cells, and secreted in the medium was abnormal. Bands representing the mature α-chains of type I collagen were significantly broadened in the cell layer and in the medium fraction, and migrated somewhat faster in comparison to the control. Processing of the N-propeptide of type I collagen is delayed in P1.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a62abfb3-80d1-46fd-826f-1e206f124b48","type":"EvidenceLine","dc:description":"This score is upgraded by 0.5 points to reflect the Gly-X-Y substitution.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a62abfb3-80d1-46fd-826f-1e206f124b48_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15728585","allele":{"id":"https://genegraph.clinicalgenome.org/r/bcc95f72-4d5b-43ad-b59d-7d3daafa26f2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.608G>T (p.Gly203Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA291548107"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a62abfb3-80d1-46fd-826f-1e206f124b48_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Underwent 70–88% cleavage, suggesting that helices with one or two normal pro-α1(I) chains were processed, whereas the 25% of helices containing two mutant chains could not be cleaved.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f0087472-fb92-4613-ab81-34ec9a3c4f72","type":"EvidenceLine","dc:description":"This score is upgraded by 0.5 points to reflect the Gly-X-Y substitution.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f0087472-fb92-4613-ab81-34ec9a3c4f72_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17078022","allele":{"id":"https://genegraph.clinicalgenome.org/r/adb63f81-92e3-4b2c-8227-1a881bfab27e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.590G>A (p.Gly197Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA291548127"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f6890f4e-3169-4ec7-befd-9c4d2757af42","type":"EvidenceLine","dc:description":"This score is upgraded by 0.5 points to reflect the Gly-X-Y substitution.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f6890f4e-3169-4ec7-befd-9c4d2757af42_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15728585","allele":{"id":"https://genegraph.clinicalgenome.org/r/bcc95f72-4d5b-43ad-b59d-7d3daafa26f2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/f6890f4e-3169-4ec7-befd-9c4d2757af42_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Underwent 70–88% cleavage, suggesting that helices with one or two normal pro-α1(I) chains were processed, whereas the 25% of helices containing two mutant chains could not be cleaved.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c722a6ae-d156-41a2-9d8f-6290c46e8a5b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c722a6ae-d156-41a2-9d8f-6290c46e8a5b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17206620","allele":{"id":"https://genegraph.clinicalgenome.org/r/10dd389f-9126-41ba-bd6f-811c2afe530b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.3196C>T (p.Arg1066Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8644546"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/c722a6ae-d156-41a2-9d8f-6290c46e8a5b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Collagen fibrils in the dermis of the proband have decreased fibril density and increased diameter compared to controls. Proband procollagen resistant to processing by N-propeptidase (ADAMTS2) exhibits kinking approximately 30 nm from the C-terminus of the helical region. Disulfide-bonded dimers of a(I) chains formed inefficiently in helices containing two mutant chains.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11}],"evidenceStrength":"Definitive","sequence":6999,"specifiedBy":"GeneValidityCriteria9","strengthScore":15,"subject":{"id":"https://genegraph.clinicalgenome.org/r/MIzzau_zM08","type":"GeneValidityProposition","disease":"obo:MONDO_0030854","gene":"hgnc:2197","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ac0eb1d7-5309-48a0-acd8-53de284f4e4b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}